RESMED INC — Director's Dealing 2024

Nov 27, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2024-11-25

Reporting Person: Farrell Michael J. (Chief Executive Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-11-27	ResMed Common Stock	G	2000	—	Disposed	2090	Indirect
2024-11-27	ResMed Common Stock	G	2000	—	Acquired	2000	Indirect
2024-11-27	ResMed Common Stock	S	2000	$249.665	Disposed	0	Indirect

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-11-25	ResMed Common Stock Options	$249.56	A	33036	Acquired	2031-11-25	ResMed Common Stock (33036)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
ResMed Common Stock	455472	Direct

Footnotes

F1: Gift of shares transferred to The Lisette and Michael Farrell Family Foundation, Mr. Farrell retains dispositive power over remaining shares.

F2: Gift of shares transferred from The Lisette and Michael Farrell Family Trust, Mr. Farrell retains dispositive power over the gifted shares.

F3: Represents date options first become exercisable. Options vest 1/3 per year.